Early Phase Clinical Cancer Prevention Consortium
The Early Phase Clinical Cancer Prevention Consortium (ClinCaP) is part of the NCI Cancer Prevention Clinical Trials Network (CP-CTNet). The lead academic organization of ClinCaP is the University of Michigan, and there are 12 Affiliated Organizations involved in trial development and conduct.
Welcome to ClinCaP
The Early Phase Clinical Cancer Prevention Consortium (ClinCaP) is a consortium of institutions administered by the University of Michigan. We develop and conduct Phase I and II trials to identify how new agents can be used for cancer prevention. The goal is prioritize agents for eventual testing in larger Phase III trials.
The ClinCaP Consortium is organized around organ site working groups . The working groups allow researchers and clinicians from all our affiliated organizations to share their expertise and collaborate in the development of new trials.
Each working group has about 10-20 members, and they meet monthly by zoom calls. At the present time we have four organ site working groups listed below.
The Beast Cancer Prevention Working Group is led by Dr. Carol Fabian and Dr. Bruce Kimler at the University of Kansas
The Upper GI Cancer Prevention Working Group is led by Dr. Amitabh Chak at Case Western Reserve University
The Lower GI Cancer Prevention Working Group is led by Dr. Dean Brenner at the University of Michigan and Dr. Carol Burke at Cleveland Clinic
The Genitourinary Cancer Prevention Working Group is led by Dr. Steven Clinton at Ohio State University